Nicole LaBrosse
Director of Finance/CFO chez HALOZYME THERAPEUTICS, INC.
Fortune : 629 726 $ au 31/03/2024
Profil
Nicole LaBrosse is currently the Director at Antares Pharma, Inc. and the Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. She previously worked as an Auditor at PricewaterhouseCoopers LLP from 2004 to 2015.
Ms. LaBrosse has an undergraduate and graduate degree from Bentley University and a graduate degree from McCallum Graduate School of Business.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
26/02/2024 | 15 480 ( 0,01% ) | 629 726 $ | 31/03/2024 |
Postes actifs de Nicole LaBrosse
Sociétés | Poste | Début |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 02/02/2022 |
ANTARES PHARMA, INC. | Director/Board Member | 24/05/2022 |
Anciens postes connus de Nicole LaBrosse
Sociétés | Poste | Fin |
---|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01/01/2015 |
Formation de Nicole LaBrosse
McCallum Graduate School of Business | Graduate Degree |
Bentley University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |